Sankey It
Loading...
Pfizer Inc. Q4 FY2025 income statement | Sankey It
Sankey It · PFE
Pfizer Inc. Q4 FY2025 income statement
USD · quarter ended 2025-12-31
Q2 FY2026
Q1 FY2026
Q4 FY2025
Q3 FY2025
Q2 FY2025
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Pfizer Inc. Q4 FY2025 income statement
Flow diagram with 6 nodes and 5 flows for Pfizer Inc. Q4 FY2025 income statement. Values: Revenue US$17.6B, Cost of Revenue US$5.3B, Gross Profit US$12.3B, Operating Expenses US$8.6B, Operating Income US$3.7B, Other Expense US$5.3B.
Revenue
US$17.6B
Cost of Revenue
(US$5.3B)
30% of revenue
Gross Profit
US$12.3B
70% margin
Operating Expenses
(US$8.6B)
49% of revenue
Operating Income
US$3.7B
21% margin
Other Expense
(US$5.3B)
Actual other expense was $5.3B
30% of revenue
Net / profit
Tax / cost
Copy link
Share on X
Open full screen